本文报道慢性萎缩性胃炎(CAG)49例,其中25例用硫糖铝治疗,24例用胃得宁治疗(对照),两组病人均同时服用胃蛋白酶合剂及庆大霉素(2周),疗程3月。治疗后硫糖铝组由CAG逆转为浅表胃炎及萎缩程度减轻者共占72％,而对照组仅占25％,P<0.01。上腹部疼痛症状,硫糖铝组有效率92％,而对照纽为54％,P<0.01。认为该疗法值得临床采用。 In this paper, 49 cases of chronic atrophic gastritis (CAG) were reported, of which 25 cases were treated with sucralfate and 24 cases were treated with verapamil (control). Both groups also took pepsin and gentamicin (2 weeks) , Treatment in March. After treatment, the ratio of sucralfate to superficial gastritis and atrophy of CSP were 72%, while the control group only accounted for 25%, P <0.01. Upper abdominal pain symptoms, sucralfate group efficiency of 92%, while the control of New Zealand was 54%, P <0.01. That the treatment is worth clinical use.